Clinical trial
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
NCT00352027 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00352027 |
|---|---|
| Title | Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma |
| Official title | Stanford V Chemotherapy With Low-Dose Tailored-Field Radiation Therapy for Intermediate Risk Pediatric Hodgkin Lymphoma |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Lymphoma |
| Intervention type | Biological, Drug, Procedure |
| Interventions | Adriamycin®, Vinblastine, Nitrogen Mustard, Cyclophosphamide, Vincristine, Bleomycin, Etoposide, Prednisone, G-CSF, Radiotherapy |
| Enrollment | 81 |
| Start date | Jul 20, 2006 |
| Primary completion | May 1, 2015 |
| Completion | Nov 15, 2022 |
| First posted | Jul 14, 2006 |
| Last update posted | Sep 22, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: